喹噁啉-2-甲胺 | 131052-78-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 中文名称: 喹噁啉-2-甲胺
• 中文别名: 2-(氨甲基)喹喔啉
• 英文名称: C-quinoxalin-2-yl-methylamine
• 英文别名: C-Chinoxalin-2-yl-methylamin；2-aminomethylquinoxaline；Quinoxalin-2-ylmethanamine
• CAS: 131052-78-3
• 化学式: C₉H₉N₃
• 分子量: 159.191
• InChiKey: BVAQGRPUYKZUDD-UHFFFAOYSA-N

物化性质

• 沸点：
  290.9±25.0 °C(Predicted)
• 密度：
  1.224±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  51.8
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险品标志：
  C
• 安全说明：
  S26,S36/37/39,S45
• 危险类别码：
  R34
• 海关编码：
  2933990090

SDS

Name:	2-Quinoxalinylmethylamine 97% Material Safety Data Sheet
Synonym:
CAS:	131052-78-3

Section 1 - Chemical Product MSDS Name:2-Quinoxalinylmethylamine 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
131052-78-3	2-Quinoxalinylmethylamine	97%	unlisted

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 131052-78-3: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid or liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H9N3
Molecular Weight: 159.19

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 131052-78-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Quinoxalinylmethylamine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.*
Hazard Class: 8
UN Number: 3259
Packing Group: III
IMO
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 3259
Packing Group: III
RID/ADR
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 3259
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 131052-78-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 131052-78-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 131052-78-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(bromomethyl)quinoxaline 、 喹噁啉-2-甲胺 以23%的产率得到p-[N-(3,4-dihydro-2-methyl-3-pivaloyloxymethyl-4-oxoquinazolin-6-ylmethyl)-N-(prop-2-ynyl)amino]-N-(quinoxalin-2-ylmethyl)benzamide
  参考文献：
  名称：

  Quinazoline derivatives possessing anti-tumor activity

  摘要：

  该发明涉及喹唑啉衍生物或其药用盐，具有抗肿瘤活性；以及其制备方法；以及含有它们的药物组合物。 该发明提供了一种喹唑啉的结构式：其中R.sup.1是氢或氨基，或每个最多6个碳原子的烷基或烷氧基；或R.sup.1是取代的每个最多3个碳原子的烷基或烷氧基；R.sup.2是氢，烷基，烯基，炔基，羟基烷基，卤代烷基或氰基烷基，每个最多6个碳原子；Ar是苯基或杂环烯；L是下式的基团：--CO.NH--，--NH.CO--，--CO.NR.sup.3--，--NR.sup.3.CO--，--CH.dbd.CH--，--CH.sub.2O--，--OCH.sub.2--，--CH.sub.2S--，--SCH.sub.2--，--CO.CH.sub.2--，--CH.sub.2.CO--或--CO.O--，其中R.sup.3是最多6个碳原子的烷基；Y是芳基或杂芳基或其氢化衍生物：或Y是下式的基团：--A--Y.sup.1，其中A是烷基，环烷基，烯基或炔基，每个最多6个碳原子，Y.sup.1是芳基或杂芳基或其氢化衍生物；或其药用盐。

  公开号：

  US05089499A1
• 作为产物：
  描述：

  N-quinoxalin-2-ylmethyl-phthalimide 在 乙醇 、 一水合肼 作用下， 生成 喹噁啉-2-甲胺
  参考文献：
  名称：

  Borkovec et al., Chemicke Listy, 1954, vol. 48, p. 717,720

  摘要：

  DOI：

文献信息

• Preparation containing quinoxaline derivatives
  申请人：——

  公开号：US20030207886A1

  公开（公告）日：2003-11-06

  The invention relates to the use of quinoxaline derivatives as photostable UV filters in cosmetic and pharmaceutical preparations for protecting the human epidermis or human hair against UV radiation, especially in the 280-400 nm range.

  该发明涉及在化妆品和药物制剂中使用喹喔啉衍生物作为光稳定的紫外线过滤剂，用于保护人类表皮或人类头发免受紫外线辐射的影响，特别是在280-400纳米范围内。
• [EN] CHEMICAL PROBES OF LYSYL OXIDASE-LIKE 2 AND USES THEREOF<br/>[FR] SONDES CHIMIQUES DE LYSYL OXYDASE DE TYPE 2 ET LEURS UTILISATIONS
  申请人：PHARMAKEA INC

  公开号：WO2018048928A1

  公开（公告）日：2018-03-15

  Described herein are probe compounds that interact with the LOXL2 receptor, methods of making such probe compounds, and methods of using such probe compounds in vitro and in vivo.

  本文描述了与LOXL2受体相互作用的探针化合物，制备这种探针化合物的方法，以及在体外和体内使用这种探针化合物的方法。
• Novel tethers in ketolide antibiotics
  作者：Takushi Kaneko、Karina Romero、Bryan Li、Richard Buzon

  DOI：10.1016/j.bmcl.2007.07.018

  日期：2007.9

  Novel macrolide antibiotics which contain a methylerie unit between two nitrogen atoms of carbarnate groups or between two nitrogen atoms of one carbarnate and one urea group were synthesized using the Curtius rearrangement. Such linkers were shown to be stable under physiological conditions, and the resulting ketolides show potent in vitro and in vivo activity against macrolide-resistant respiratory pathogens. The SAR of various heterocycles and linkers was established. (C) 2007 Elsevier Ltd. All rights reserved.
• Anti-tumour agents
  申请人：IMPERIAL CHEMICAL INDUSTRIES PLC

  公开号：EP0373891B1

  公开（公告）日：1994-11-02
• ZUBEREITUNG ENTHALTEND CHINOXALINDERIVATE
  申请人：Merck Patent GmbH

  公开号：EP1267819A2

  公开（公告）日：2003-01-02